SCHEMBL2653080

SCHEMBL2653080

COC(=O)c1cc(Cl)c(CCCO)s1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4A11 Q02928 4/20 0.43
CYP4F2 P78329 3/20 0.39
MRGPRX4 Q96LA9 1/20 0.39
OPRD1 P41143 1/20 0.38
HPGD P15428 4/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
MAPK1 P28482 2/20 0.37
TSHR P16473 2/20 0.37
NPSR1 Q6W5P4 2/20 0.37
ATM Q13315 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 3/20 0.36
KDM4E B2RXH2 3/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CTPS1 P17812 1/20 0.36
CSNK2A2 P19784 1/20 0.35
KDR P35968 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22607908 0.91 MRGPRX4 (0.40) CYP4A11CYP4F2MRGPRX4OPRD1HPGD
SCHEMBL2654739 0.84 DAO (0.52) MRGPRX4TSHRALDH1A1KDM4EDAO
SCHEMBL7836036 0.83 CYP4A11 (0.44) CYP4A11CYP4F2OPRD1HPGDL3MBTL1
SCHEMBL22607818 0.83 MRGPRX4 (0.39) MRGPRX4OPRD1HPGDL3MBTL1MAPK1
SCHEMBL23022514 0.80 CSNK2A2 (0.41) CYP4A11CYP4F2MRGPRX4OPRD1HPGD
SCHEMBL22607885 0.78 MRGPRX4 (0.39) MRGPRX4OPRD1HPGDL3MBTL1MAPK1
SCHEMBL22607939 0.74 MRGPRX4 (0.31) MRGPRX4HPGDALDH1A1CYP1A2CYP2C19
SCHEMBL22624629 0.73 MRGPRX4 (0.36) MRGPRX4HPGDL3MBTL1MAPK1TSHR
SCHEMBL22607895 0.73 USP2 (0.47) CYP4A11CYP4F2OPRD1HPGDL3MBTL1
SCHEMBL23013272 0.72 HTR4 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856090-A2 SUBSTITUTED THIOPHENE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2007-11-21 EP disclosed
WO-2006086488-A2 SUBSTITUTED THIOPHENE DERIVATIVES AS GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES ELI LILLY AND COMPANY (US) 2006-08-17 WO disclosed